Investors' COVID Vax Suit Against Drugmaker Tossed
Citing inadequate claims, a Pennsylvania federal judge on Friday tossed a proposed class action against biopharmaceutical company Ocugen Inc. filed by investors claiming the company made misleading statements regarding a COVID-19...To view the full article, register now.
Already a subscriber? Click here to view full article